CD4 Ligand IL-16 Inhibits the Mixed Lymphocyte Reaction

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1958-1964

  Theodore, Arthur C ^a,b   Center, David M ^a   Nicoll, John ^a   Fine, Gregg ^a   Kornfeld, Hardy ^a   Cruikshank, William W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 16; INTERLEUKIN 2; LIGAND; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; INTERPHASE; KINETICS; METABOLISM; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL;

ANTIGENS, CD4; DNA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-16; INTERLEUKIN-2; INTERPHASE; KINETICS; LEUKOCYTES, MONONUCLEAR; LIGANDS; LYMPHOCYTE CULTURE TEST, MIXED; RECOMBINANT PROTEINS;

EID: 0030240114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. + effector T cells recognize products of different major histocompatability complex regions. Proc. Natl. Acad. Sci. USA 79:4395.
2. Biddison, W. E., P. E. Rao, M. A. Talle, G. Goldstein, and S. Shaw. 1982. Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. J. Exp. Med. 156:1065.
3. Gay, D., P. Maddon, R. Sekaly, M. A. Talle, M. Godfrey, E. Long, G. Goldstein, L. Chess, R. Axel, J. Kappler, and P. Marrack. 1987. Functional interaction between human T-cell protein CD4 and the major histocompatability complex HLA-DR antigen. Nature 328:626.
4. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
5. Jenkins, M. K., J. D. Ashwell, and R. H. Schwartz. 1988. Allogeneic non-T spleen cells restore the unresponsiveness of normal T cell clones stimulated with antigen and chemically modified antigen presenting cells. J. Immunol. 140:3324.
6. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617.
7. Malkovsky, M., and P. B. Medawar. 1984. Is immunologic tolerance (nonresponsiveness) a consequence of interleukin 2 deficit during the recognition of antigen? Immunol. Today 5:340.
8. Nossal, G. J. V. 1989. Immunological tolerance: collaboration between antigen and lymphokines. Science 245:147.
9. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
10. Lamb, J. R., E. D. Zanders, W. Sewell, M. J. Crumpton, M. Feldmann, and M. J. Owen. 1987. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 pr CD3/Ti receptor pathways. Eur. J. Immunol. 17:1641.
11. Tomonari, K. 1985. T cell receptor expressed on an autoreactive T cell clone. Clone 4. I. Induction of various T-receptor functions by anti-T idiotypic antibodies. Cell. Immunol. 96:147.
12. Lamb, J. R., B. J. Skidmore, N. Green, J. M. Chiller, and M. Feldmann. 1983. Induction of tolerance in the influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemaglutinin. J. Exp. Med. 157:1434.
13. + lymphocytes. Eur. J. Immunol. 24:3216.
14. Malkovsky, M., P. B. Medawar, D. R. Thatcher, J. Toy, R. Hunt, L. S. Rayfield, and C. Dore. 1985. Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc. Natl. Acad. Sci. USA 82:536.
15. Holan, V. 1987. Successful induction of specific hyporeactivity to rat skin xenografts in newborn mice. Transplantation 6:809.
16. Holan, V., J. R. Lamb, and M. Malkovsky. 1991. Immunological tolerance and lymphokines. CRC Crit. Rev. Immunol. 10:481.
17. Desquenne-Clark, L., H. Kimura, and W. K. Silvers. 1988. The influence of interleukin 2 on the persistence of tolerance. Transplantation 46:774.
18. Tempelis, C. H., K. Hala, G. Kromer, K. Schauenstein, and G. Wick. 1988. Failure to alter neonatal transplantation tolerance by the injection of interleukin 2. Transplantation 45:449.
19. Liegler, T. J., and D. P. Stites. 1994. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J. Acquired Immune Defic. Syndr. 7:340.
20. Chace, J. H., J. S. Cowdery, and E. H. Field. 1994. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152:405.
21. Miller, S. B., H. Tse, A. J. Rosenspire, and S. R. King. 1992. CD4-independent inhibition of lymphocyte proliferation mediated by HIV-1 envelope glycoproteins. Virology 191:973.
22. Mittler, R. S., and M. K. Hoffman. 1989. Synergism between HIV and gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380.
23. Chirmule, N., V. S. Kalyanaraman, N. Oyaizu, H. B. Slade, and S. Pahwa. 1990. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 75:152.
24. + T cells. Transplantation 54:483.
25. + lymphocytes and monocytes. J. Immunol. 138:3817.
26. Kornfeld, H., W. W. Cruikshank, S. P. Pyle, J. S. Berman, and D. M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335:445.
27. lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J. Biol. Chem. 270:17081.
28. + T cells inhibits the binding activity of NF-AT, NF-κB, and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur. J. Immunol. 24:2646.
29. Clayton, A. K., M. Sieh, D. A. Pious, and E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II versus HIV-1 gp120 binding. Nature 339:548.
30. Theodore, A. C., H. Kornfeld, R. P. Wallace, and W. W. Cruikshank. 1994. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J. Acquired Immune Defic. Syndr. 7:899.
31. Wahl, S. M., J. B. Allen, S. Gartner, J. M. Orenstein, M. Popovic, D. E. Chenoweth, L. O. Arthur, W. L. Farrar, and L. M. Wahl. 1989. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 142:3553.
32. Stevenson, M., X. Zhang, and D. J. Volsky. 1987. Down-regulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J. Virol. 61:3741.
33. + monocytoid cell line. J. Virol. 63:3748.
34. Liu, Y., B. Jones, A. Aruffo, K. M. Sullivan, P. S. Linsley, and C. A. Janeway. 1992. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:437.
35. Morel, P., J. F. Nicolas, J. Wijdenes, and J. P. Revillard. 1992. Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody. Clin. Immunol. Immunopathol. 64:248.
36. Horneff, G., F. Emmrich, and G. R. Burmester. 1993. Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies. Br. J. Rheumatol. 32 s4:39.
37. Goldberg, D., P. Morel, L. Chatenoud, C. Boitard, C. J. Menkes, P. H. Bertoye, J. P. Revillard, and J. F. Bach. 1991. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J. Autoimmun. 4:617.
38. Bank, I., and L. Chess. 1985. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 162:1294.
39. + T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell. Immunol. 161:72.
40. Choy, E. H., J. Adjaye, L. Forrest, G. H. Kingsley, and G. S. Panayi. 1993. Chimeric anti-CD4 monoclonal antibody crosslinked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes. Eur. J. Immunol. 23:2676.
41. + T cells in vitro: differential induction of apoptosis in these cells. J. Immunol. 152:330.
42. + cells during rnurine AIDS. Cell. Immunol. 151:392.
43. Olive, D., and C. Mawas. 1993. Therapeutic applications of anti-CD4 antibodies. Crit. Rev. Ther. Drug. Carrier Syst. 10:29.
44. Burmester, G. R., and F. Emmrich. 1993. Anti-CD4 therapy in rheumatoid arthritis. Clin. Exp. Rheumatol. 11 8s:139.
45. Waldmann, H., and S. Cobbold. 1993. Monoclonal antibodies for the induction of transplantation tolerance. Curr. Opin. Immunol 5:753.
46. Center, D. M., and W. W. Cruikshank. 1982. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol. 128:2563.
47. Cruikshank, W. W., and D. M. Center. 1982. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol. 128:2569.
48. Berman, J. S., D. J. Beer, W. W. Cruikshank, A. C. Theodore, and D. M. Center. 1985. Chemoattractant lymphokines specific for the helper/induces T-lymphocyte subset. Cell. Immunol. 95:105.
49. Rand, T., W. W. Cruikshank, D. M. Center, and P. F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173:1521.
50. Cruikshank, W. W., J. L. Greenstein, A. C. Theodore, and D. M. Center. 1991. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes. J. Immunol. 146:2928.
51. Cruikshank, W. W., D. M. Center, N. Nisar, M. Wu, B. Natke, A. C. Theodore, and H. Kornfeld. 1994. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc. Natl. Acad. Sci. USA 91:5109.
52. Issekutz, A. C. 1983. Removal of Gram-negative endotoxin from solution by affinity chromatography. J. Immunol. Methods 61:275.
53. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
54. Kozak, R. W., C. E. Moody, L. Staiano-Coico, and M. E. Weksler. 1982. Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogenic reactive T lymphocytes. J. Immunol. 128:1723.
55. Field, E. H., and G. C. Becker. 1992. Blocking of mixed lymphocyte reaction by spleen cells from total lymphoid-irradiated mice involves interruption of the IL-2 pathway. J. Immunol. 148:354.
56. Weinhold, K. J., H. K. Lyerly, S. D. Stanley, S. A. Austin, T. J. Mathews, and D. P. Bolognesi. 1989. HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091.
57. + T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87:4022.
58. Baldari, C. T., E. Milia, M. M. Di Somma, F. Baldoni, S. Valitutti, and J. I. Telford. 1995. Distinct signaling properties identify functionally different CD4 epitopes. Eur. J. Immunol. 25:1843.
59. Landau, N. R., M. Warton, and D. R. Littman. 1988. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 334:159.
60. Lamarre, D., A. Ashkenazi, S. Fleury, D. H. Smith, R.-P. Sekaly, and D. J. Capon. 1989. The MHC-binding and gp120-binding functions of CD4 are separable. Science 245:743.
61. Sakihama, T., A. Smolyar, and E. L. Reinherz. 1995. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol. Today 16:581.
62. Sakihama, T., A. Smolyar, and E. L. Reinherz. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92:6444.
63. Geppert, T. D., and P. E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton: effect of cross-linking and activation. J. Immunol. 146:3298.
64. + T cells from HIV-gp120-induced apoptosis. Eur. J. Immunol. 25:2917.
65. + T cell populations. Eur. J. Immunol. 25:2907.
66. Westendorp, M. O., R. Frank, C. Ochsenbbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
67. + T cells. J. Gen. Vir. 76:681.
68. Radrizzani, M., P. Accornero, A. Amidei, A. Aiello, D. Delia, R. Kurrle, and M. P. Columbo. 1995. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 crosslinking and CD3/TCR activation or by IL-2 deprivation. Cell. Immunol. 161:14.
69. Ledbetter, J. A., C. H. June, P. S. Rabinovitch, A. Grossman, T. T. Tsu, and J. B. Imboden. 1988. Signal transduction through CD4 receptors: stimulatory vs inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur. J. Immunol. 18:525.
70. Dianzani, U., A. Shaw, B. K. Al-ramadi, R. T. Kubo, and C. A. Janeway. 1992. Physical association of CD4 with the T cell receptor. J. Immunol. 148:678.
71. Szabo, G., Jr., J. L. Weaver, P. S. Pine, P. E. Rao, and A. Aszalos. 1995. Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET study. Biophys. J. 68:1170.
72. Diamond, D. J., P. Szalay., D. Symer, P. Hao, H. S. Shin, R. Z. Dintzis, H. M. Dintzis, E. L. Reinherz, and R. F. Siliciano. 1991. Major histocompatibility complex independent T cell receptor-antigen interaction: functional analysis using fluorescein derivatives. J. Exp. Med. 174:229.
73. Manger, B., A. Weiss, J. B. Imboden, T. Laing, and J. D. Stobo. 1987. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex: effects of stimulation with soluble or immobilized CD3 antibodies. J. Immunol. 139:2755.
74. Anderson, P., M.-L. Blue, and S. F. Schlossman. 1988. Comodulation of CD3 and CD4. J. Immunol. 140:1732.
75. Rivas, A. S. Takada, J. Koide, G. Sonderstrup-McDevitt, and E. G. Engleman. 1988. CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. J. Immunol. 140:2912.